Advertisement
Learn more about this specific study/application/innovation directly from the authors of this article.
(opens a new window to the external site)Published on in Vol 6, No 11 (2022): November
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/41914, first published
.
![The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups](https://asset.jmir.pub/assets/a9de9bcc0fff8c879fbc00b03a7e7efb.png 480w,https://asset.jmir.pub/assets/a9de9bcc0fff8c879fbc00b03a7e7efb.png 960w,https://asset.jmir.pub/assets/a9de9bcc0fff8c879fbc00b03a7e7efb.png 1920w,https://asset.jmir.pub/assets/a9de9bcc0fff8c879fbc00b03a7e7efb.png 2500w)
1 Aurametrix, MEBO Research, Miami, FL, United States